[1]
T. Karabin, G. Biala, and M. Kruk-Slomka, “The recent guidelines for pharmacotherapy of Parkinson’s Disease”, Curr. Issues Pharm. Med. Sci., vol. 35, no. 2, pp. 80–85, Aug. 2022, doi: 10.2478/cipms-2022-0015.